Schedule online now


Syneron Launches New Sublative iD™ Focal Tip To Reduce Fine Wrinkles In Hard to Reach Areas Around The Eyes and Mouth. The iD™ Focal Tip ensures Company’s commitment to elōs Plus™, eMatrix™.

Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic products and technologies, announced the launch of a new Sublative iD™ Focal Tip for challenging treatment areas such as the nasolabial fold (“smile lines”) and periorbital rim (“around the eyes”). The new Sublative iD Focal Tip will be available for use on all of Syneron’s proprietary Sublative™ compatible systems, which includes elōs Plus™, eTwo™ and eMatrix™.

“We are pleased to provide our customers with the new Sublative iD Focal Tip for use with Syneron’s unique Sublative treatment systems. This offering was developed to meet the needs of our customers and expand their treatment capabilities to better serve their patients,” said Louis P. Scafuri, Chief Executive Officer at Syneron. ” This new tip broadens the applications of our sublative hand piece which, in turn, expands our customers ROI and profitability from the eMatrix, eTwo and elōs Plus devices.”
The new Sublative iD Focal Tip features an array of 44 pins on a re-connectable compact tip design that is compatible with any Sublative applicator. “Many of my patients, particularly my younger patients, wish to consider non-surgical as well as surgical options for improvement in the early signs of aging around their eyes,” said Alan Gold, M.D., F.A.C.S board certified plastic surgeon in Great Neck, New York. “Using energy-based devices to treat around the periorbital area has previously been technically challenging primarily due to the size of the available applicators. However, the new Sublative iD Focal Tip has been intelligently designed for greater maneuverability and better fit in the smaller, harder to contour areas making it an attractive option which has allowed me to expand the Sublative treatment in my practice.”    

Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. The Company’s aspiration and commitment to innovation expands Syneron’s offering beyond medical device into the largest in-demand applications in beauty - skin lightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at